Clinical Trial Update: A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating P2202 for Type 2 Diabetes Mellitus sponsored by Piramal Enterprises Limited has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• P2202

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED